4
Changes in Ownership
Solid Biosciences Inc. Filed Acc 0000950170-25-022196
Chief Operating Officer sold 5,561 shares at $3.96 ($22,022)
- Chief Operating Officer acquired 14,687 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Howton David T Chief Operating Officer | 2025-02-13 | Option exercise 10b5-1 | +14,687 | 30,350 | D | ||
| Howton David T Chief Operating Officer | 2025-02-14 | Sale 10b5-1 | −5,561 | $3.96 | $22,022 | 24,789 | D |
| Derivatives | |||||||
| Howton David T Chief Operating Officer | 2025-02-13 | Option exercise · Restricted Stock Units 10b5-1 | −14,687 | 44,063 | D | ||
| Open-market sales · 5,561 sh · avg $3.96 · $22,022 | |||||||
Loading xslF345X05/ownership.xml…